CEO Ameet Mallik stated the company "continue[s] to focus on execution and delivering on our commercial strategy, maintaining ZYNLONTA as a differentiated treatment option for third-line plus DLBCL ...
Detailed price information for Adc Therapeutics Sa (ADCT-N) from The Globe and Mail including charting and trades.
The MarketWatch News Department was not involved in the creation of this content. Data highlights ability of Akari's ADC payload, PH1, to suppress the levels of the AR-V7 receptor that is responsible ...
Global Lung Cancer Antibody Drug Conjugates Market Witnessing Exponential Growth Says Kuick Research Delhi, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Global Lung Cancer Antibody Drug Conjugates Market ...
Montreal, Quebec--(Newsfile Corp. - July 14, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug ...
6d
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback